NCT07431021 Children's Health, Respiratory Inflammation and Short-term Air Pollution
| NCT ID | NCT07431021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Queen Mary University of London |
| Condition | Asthma Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 330 participants |
| Start Date | 2025-10-20 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 330 participants in total. It began in 2025-10-20 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to see if physical activity in high air pollution is worse than rest in high air pollution.
Eligibility Criteria
Inclusion Criteria: * Attending schools in Central and East London that have been recruited to the study Exclusion Criteria: * Not able to engage with PE lessons on safety grounds, reported by their parents. * Children with learning or physical disabilities sufficient for them to be unable to give informed assent to the study, or to carry out study procedures
Contact & Investigator
James Scales, PhD
PRINCIPAL INVESTIGATOR
Queen Mary University London
Frequently Asked Questions
Who can join the NCT07431021 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 11 Years, studying Asthma Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07431021 currently recruiting?
Yes, NCT07431021 is actively recruiting participants. Contact the research team at j.scales@qmul.ac.uk for enrollment information.
Where is the NCT07431021 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT07431021 clinical trial?
NCT07431021 is sponsored by Queen Mary University of London. The principal investigator is James Scales, PhD at Queen Mary University London. The trial plans to enroll 330 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.